Medical comms - Articles

It is estimated that long term sickness absence costs the UK economy almost £9 billion each year due to 140 million days lost as sickness absence. With an already failing economy, it is no wonder then that alongside a number of employment law reforms aimed at tackling the economic crisis, this is another area under scrutiny.
It is estimated that long term sickness absence costs the UK economy almost £9 billion each year due to 140 million days lost as sickness absence. With an already failing economy, it is no wonder then that alongside a number of employment law reforms aimed at tackling the economic crisis, this is another area under scrutiny.Traditionally, employers have expected an employee’s doctor to assess their capability to work. However, an independent review into sickness absence…

Employee Value Propositions (EVP) and attractive incentives are once again in focus as employers consider candidates who have potential rather than solely those who are an exact fit for the role, says recruiting experts Hays.
Employee Value Propositions (EVP) and attractive incentives are once again in focus as employers consider candidates who have potential rather than solely those who are an exact fit for the role, says recruiting experts Hays.According to Hays, this is occurring for candidates who have transferable skills or potential, and express a desire to move for career development rather than salary reasons. “Employers are going back to the drawing board and seeking to lure candidates by looking at their ‘what’s in it for you?’ appeal,” says Emma Charnock, Regional Director of Hay…

ABBYY and partner Document Genetics team up to streamline critical business processes
ABBYY and partner Document Genetics team up to streamline critical business processesBackgroundIn the face of the growing assortment of pharmaceutical products, PharmacoVigilance, or the pharmacological science of detecting and assessing the side effects of medicines, has become an important issue to both drug companies and consumers alike. In order to identify new information about the hazards associated with medicines and to prevent harm to patients, data from healthcare providers and individuals need to be collected, monitored, researched, assessed and evaluated. The PV evaluation process, however, involves significant amounts of time, particularly to process the large volume of documents.Because of the…

New data on UCB’s anti-TNF biologic certolizumab pegol (Cimzia), disclosed this week in several poster presentations during the annual meeting of the American College of Rheumatology (ACR), show the treatment works well in rheumatoid arthritis (RA) patients irrespective of prior exposure to other biologics, and that results are sustained over 28 weeks.
New data on UCB’s anti-TNF biologic certolizumab pegol (Cimzia), disclosed this week in several poster presentations during the annual meeting of the American College of Rheumatology (ACR), show the treatment works well in rheumatoid arthritis (RA) patients irrespective of prior exposure to other biologics, and that results are sustained over 28 weeks. A new post-hoc data analysis from the RAPID 1 study also confirms that good responses to…

We’re seeing increasing demand for pharma marketing solutions to be based on the iPad, and it’s not hard to see why. The pace at which the industry continues its move away from paper-based detail aids seems to be increasing. But what’s interesting is that remote ‘self-service’ edetailing does not seem to be growing at the same rate. The predicted disintermediation of the traditional field sales model hasn’t happened.
We’re seeing increasing demand for pharma marketing solutions to be based on the iPad, and it’s not hard to see why. The pace at which the industry continues its move away from paper-based detail aids seems to  be increasing. But what’s interesting is that remote ‘self-service’ edetailing does not seem to be growing at the same rate. The predicted disintermediation of th…

CPL Pharma Lager and Vertrieb GmbH designs and performs tailor-made logistics solutions for the healthcare and pharmaceutical industry throughout Germany and Austria.
CPL Pharma Lager and Vertrieb GmbH designs and performs tailor-made logistics solutions for the healthcare and pharmaceutical industry throughout Germany and Austria.CPL’s approach to distribution is predominantly based on the principle that a wide range of goods have to meet an extremely high availability – from a fast-moving item to one that is rarely in demand. This is no easy task for the six planners at CPL; goods must be ordered at the right time and in the right quantity. This ordering process must also take into consideration a plethora of item indicators, such as sell-by dates.Jürgen Spindler, the manager of logistics…

In the aftermath of last year’s inconclusive General Election — and the subsequent emergence of the Coalition Government — you’d have been forgiven for thinking that ‘deficit reduction’ was the only buzzword in town.
In the aftermath of last year’s inconclusive General Election — and the subsequent emergence of the Coalition Government — you’d have been forgiven for thinking that ‘deficit reduction’ was the only buzzword in town. ‘Growth’, opposing politicians charged, was seemingly absent from the government’s fiscal vocabulary. In a more recent example of bad news for the government, earlier this week the Office for National Statistics (ONS) halved its earlier estimate for second quarter UK growth to 0.1%. Subsequently, and as David Cameron addressed the Conservative Party Conference thi…

NICE is a world-renowned, independent organisation responsible for providing national recommendations on the use of new and existing medicines and treatments within the NHS, through the Technology Appraisal Programme. The Scientific Advice Programme provides not-for-profit chargeable consulting services to companies who have products in development that may be referred for future evaluation by NICE.
NICE is a world-renowned, independent organisation responsible for providing national recommendations on the use of new and existing medicines and treatments within the NHS, through the Technology Appraisal Programme. The Scientific Advice Programme provides not-for-profit chargeable consulting services to companies who have products in development that may be referred for future evaluation by…

New drug formulations, biological agents, combination therapies and the latest pharmaceutical developments designed to improve outcomes in patients with a wide range of cancers were highlighted at EMCC 2001. Here are just a few of the highlights:
New drug formulations, biological agents, combination therapies and the latest pharmaceutical developments designed to improve outcomes in patients with a wide range of cancers were highlighted at EMCC 2001. Here are just a few of the highlights: Progression-free survival (PFS) in patients with HER2-positive metastatic breast cancer (MBC) cancer was improved by more than 40% in a clinical trial designed to assess the benefit of a new antibody drug conjugate to that of conventional first-line therapy.Dr Sara Hurvitz (Director, Breast Oncology Progr…

Science is always at its most exciting when it looks to the far horizons. And the unavoidably controversial yet incredibly promising area of stem cell science provides arguably one of the most apt examples.
Science is always at its most exciting when it looks to the far horizons. And the unavoidably controversial yet incredibly promising area of stem cell science provides arguably one of the most apt examples. Indeed even to the most disinterested layman, the idea of using the human body’s own cellular foundations to regenerate damaged organs must surely evoke at least a flicker of excitement. Conversely, and to those patients for whom stem cell science may one day represent a potential new lease on life, this really is the science of dreams.Earlier this week, and in what looks set to beco…

Social media has probably become one of the most important forms of communication and interaction to date, and it is here to stay.
Social media has probably become one of the most important forms of communication and interaction to date, and it is here to stay. It has turned the world from passive consumers into active consumers, with people increasingly taking to the internet to voice their approval or concerns about a certain product, brand or service. With over 750million active users on Facebook, and over 200million Tweeters worldwide, anyone who takes to social media to make their voices heard can have an enormous audience to hear it. It has also so far been an area that many pharmaceutical and healthcare companies have hesitated getting involved in. It is as though there is a fear…

There’s a drugs shortage in America. That the construction of such a sentence is possible seems baffling for a nation that has led the world in medical innovation for decades.
There’s a drugs shortage in America. That the construction of such a sentence is possible seems baffling for a nation that has led the world in medical innovation for decades. As I first documented back in March, America is oft cited as the global leader in drug innovation. Measured by the metric of Nobel Prizes, a 2010 CATO Institute study showed that over 60% of the recipients of the Nobel Prize for Medicine between 1969-2008 hailed from the United States. Similarly, of the six most groundbreaking medical discoveries of the past 25 years, four find their roots on American soil.Given this stellar pedigree in medical…

Esther Dyson the Great Dame of Silicon Valley, at times matriarch to Bill Gates and many other lads on the innovative circuit, wrote a harsh column August 26th on GPS CNN on ICANN gTLD. I like and respect Esther especially her technical background, we have shared the podium, but as this topic deals with the centrality of global corporate nomenclature it demands an authoritative analysis and I feel it’s my responsibility to clarify and taken the liberty to address her entire piece item by item.
What's NOT a domain name?Esther Dyson the Great Dame of Silicon Valley, at times matriarch to Bill Gates and many other lads on the innovative circuit, wrote a harsh column August 26th on GPS CNN on ICANN gTLD. I like and respect Esther especially her technical background, we have shared the podium, b…

How common is it to work during your vacation? - Take our short survey.
How common is it to work during your vacation? We're doing some research to find out more about current trends, and the amount of work people undertake on their vacation, as well as how they do it. So, if you could help us by completing our short survey, I will put your name into the hat for some PharmiWeb.com freebies. (I've got mugs, pens, mouse mats, and all sorts of goodies) Thanks for your help!- The results will be published in due course. >>>CLICK HERE TO TAKE PART IN THE SURVEY<<<

For recent graduates from science, medicine, or mathematics programs, applying for work in the ever-expanding pharmaceutical industry can be an intelligent choice for both career and financial stability. Depending on the industry upon which you choose to focus, the rules and expectations during the interview process can vary.
For recent graduates from science, medicine, or mathematics programs, applying for work in the ever-expanding pharmaceutical industry can be an intelligent choice for both career and financial stability. Depending on the industry upon which you choose to focus, the rules and expectations during the interview process can vary. Interviewing is a skill in and of itself, and there are a number of commonalities when it comes to making sure that one’s interview is succ…

Almost irrespective of the country you live in, the increasing costs of healthcare are unavoidable. For governments, the stresses are particularly acute, as both aging populations and the increasing cost of treatments add financial pressures year on year. Yet as a new study by the Institute of Fiscal Studies (IFS) confirms, we should not underestimate the extent to which the shape of the state has already changed.
Almost irrespective of the country you live in, the increasing costs of healthcare are unavoidable. For governments, the stresses are particularly acute, as both aging populations and the increasing cost of treatments add financial pressures year on year. Yet as a new study by the Institute of Fiscal Studies (IFS) confirms, we should not underestimate the extent to which the sha…

At a moment when the national discourse on international aid is grounded in pessimism, David Cameron’s pledge to commit £814m to help vaccinate the world’s poorest children provides an necessary reminder of what international aid really can achieve.
In a climate defined by fiscal retrenchment and tight purse strings, the Coalition government’s still-kept pledge to increase the UK’s international aid budget to 0.7% of GDP by 2013 has been controversial at best. International Development Secretary, Andrew Mitchell has delivered some excellent performances in defence of the policy — particularly in terms of his promises to root out waste and corruption — but the general public still remains broadly split on the issue, as this recent article by the Spectator shows. By any definition, two to one…

Certolizumab pegol (Cimzia ®) delivered rapid and consistent improvements in a broad range of rheumatoid arthritis (RA) patients after 12 weeks of treatment regardless of whether or not they had received prior TNF inhibitors or whether or not they were receiving concomitant DMARDs, concluded the latest analysis of the Phase III b REALISTIC trial presented at the European League Against Rheumatism (EULAR) meeting in London, May 25-28 (abstract FRI021).
Certolizumab pegol (Cimzia ®) delivered rapid and consistent improvements in a broad range of rheumatoid arthritis (RA) patients after 12 weeks of treatment regardless of whether or not they had received prior TNF inhibitors or whether or not they were receiving concomitant DMARDs, concluded the latest analysis of the Phase III b REALISTIC tri…

Both drugs are protease inhibitors (PIs) and are designed to block an enzyme that helps the hepatitis C virus replicate. Hepatitis C is a liver disease caused by infection with the hepatitis C virus, which is transmitted through contaminated blood. The infection can cause liver failure and liver cancer.
An advisory committee of the Food and Drug Administration (FDA) has voted unanimously that Vertex Pharmaceuticals Inc.'s (VRTX) hepatitis C drug telaprevir and Merck’s hepatitis C drug, broceprevir should be approved by the FDA. The FDA decision is expected later this month. Both drugs are protease inhibitors (PIs) and are designed to block an enzyme that helps the hepatitis C virus replicate. Hepatitis C is a liver disease caused by infection with the hepatitis C virus, which is transmitted…

Brand managers and marketing leads are always striving to gain that first step of engagement, particularly in our world of pharmaceutical manufacturing. And with good reason. Customer engagement leads to improved understanding, which drives loyalty and ultimately improved health.
Brand managers and marketing leads are always striving to gain that first step of engagement, particularly in our world of pharmaceutical manufacturing. And with good reason. Customer engagement leads to improved understanding, which drives loyalty and ultimately improved health.I believe that mobile apps present marketers with a tremendous opportunity to encourage the kind of consumer engagement we are seeking in this industry. With the launch of the iPad2, Motorola XOOM, Samsung Galaxy and numerous smartphones i…